Ajmera Realty Shares Surge After Strong FY26 Results Sets Ambitious FY27 Target UK Energy Vulnerability May Require Deeper State Intervention Amid Cost of Living Measures Kevin Warsh Sworn In as Federal Reserve Chair Amidst Presidential Pressure for Rate Cuts Market Expectations Suggest Prolonged Hold SK Hynix Reports Record Profit Driven by AI Chip Demand Chinese Investors Flock to Dividend Stocks Amid Limited Alternatives Piper Sandler Warns Prolonged Strait of Hormuz Closure Could Push Oil Prices to New Highs FLG Q1 2026 Earnings EPS Surprises to the Upside Amid Lingering Market Concerns Navient Q1 2026 Earnings EPS Surpasses Estimates as Stock Edges Higher ARVN Q1 2026 Earnings NarrowerThanExpected Loss Provides Positive Signal Amid Pipeline Progress VerifyMe Inc VRME Q4 2025 Earnings EPS Misses Estimates Amid Challenging Quarter LMT Q1 2026 Earnings Defense Giant Posts EPS Miss but Shares Edge Higher JMSB Q1 2026 Earnings EPS Surpasses Estimates Despite Modest Stock Decline NextNav Inc NN Gains 168 as Price Tests Resistance Near 2283 SVAQW Warrants Hold Steady at 031 Amid Consolidation Phase VLYPN Preferred Stock Maintains Stability Amid Modest Decline Zoetis ZTS Edges Lower Amid Sector Volatility Key Levels in Focus Arteris Inc AIP Modestly Gains as Stock Holds Above Key Support AIRelated Layoffs May Not Guarantee Stock Gains Data Suggests BUSEP Q1 2026 Earnings Preferred Stock Delivers Strong EPS Surprise Neuberger High Yield Strategies Fund NHS Holds Near Support as FixedIncome Market Awaits Clearer Signals BDCIU Q1 2026 Earnings Positive EPS Amid Limited Disclosures LMB Q1 2026 Earnings Staggering EPS Surprise of Over 1000 Masks a 224 Stock Decline CRESY Q1 2026 Earnings Strong EPS of 61402 Drives Positive Market Reaction NCR Atleos NATL Q1 2026 Earnings EPS Misses Estimates as Stock Edges Lower NTRSO Q1 2026 Earnings Northern Trust Beats EPS Estimates by 1435 Shares Dip Slightly NervGen Pharma Q3 2025 Earnings Narrowed Loss Meets Estimates But Stock Plunges 43 ABVX Q4 2025 Earnings Significant EPS Miss as DevelopmentStage Biotech Reports WiderThanExpected Loss